Search results for: 'carbon selphy pace push'

Carbon nanotubes (CNTs) are emerging as a cornerstone material for next-generation industries, enabling breakthroughs in electric vehicles, aerospace, energy storage, and flexible electronics through their unique combination of lightweight structure, exceptional electrical conductivity, and superior mechanical and thermal performance. Beyond enhanc...

The report covers the clinical trial assessment for radiodiagnostics, including PET, SPECT, and radiopharmaceuticals, comprising Alpha therapy, Beta therapy, Auger Therapy, and Theranostics. The report covers the key players in each space and their contributions to the radiopharmaceuticals landscape.The report sheds light on technology innovations ...

There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...

28 Jan 2020  |  North America  |  Market Research

Global Healthcare Cloud Computing Market, Forecast to 2023

Competitive Dynamics are Pushing Services to the Forefront

Infographics

×

Key Issues Addressed

Cloud computing in healthcare is gaining momentum as a variety of factors create a significant need for the value propositions that a successful cloud implementation promises to offer. Global healthcare cloud market revenue is expected to surge at a compound annual growth rate of 25.1% from 2018 to 2023. Cloud computing involves the use of exter...

The focus of this report is on clinical-grade remote patient monitoring (RPM). RPM is a digital solution that involves secure transmission of medical data collected on devices, via information and communication technologies, through text, sound, images or other forms needed for the prevention, diagnosis, treatment and follow-up of patients. Health ...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

A Frost & Sullivan perspective of the European Congress Radiology (ECR) - 2017 has also been covered in this research, which highlights some of the major DR systems launched in the tradeshow event. Highlights on new system features and new offerings have also been covered based on the manufacturers’ display in the event. The Growth Opportunities a...

17 Aug 2022  |  Global  |  Technology Research

Therapeutic Advances in Amyloidosis

Research Efforts and Technology Developments through Partnerships and Collaborations will Push New Therapeutic Modalities into Treatment Regimens.

Infographics

×

Amyloidosis is a rare disease caused by the accumulation and the deposition of proteins such as immunoglobulin light-chain protein in AL amyloidosis and misfolded transthyretin (TTR) protein in ATTR amyloidosis. There are a few other types of amyloidosis as well, which are either a result of a preexisting condition or are not highly prevalent. Vari...

16 Jan 2025  |  Global  |  Technology Research

Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029

The emergence of novel pathogens and the reemergence of old pathogens are driving transformational growth by pushing therapeutic advancement.

Infographics

×

Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an analysis of clinical trials for 3 treatment modaliti...